<p>A hepatitis A virus antigen comprising inactivated or attenuated hepatitis A virus particles is disclosed in the present application. The present antigen coprises both complete particles containing the hepatitis A virus RNA and immature empty particles free of the virus RNA. By using these two kinds of virus particles as materials for vaccines, the infection with hepatitis A can be prevented or treated. Moreover, the HAV antigen can be used as an immunogen for obtaining an anti-HAV antibody or immunoglobulin for imparting passive immunization to an objection animal.</p>
申请公布号
EP0339668(A2)
申请公布日期
1989.11.02
申请号
EP19890107763
申请日期
1989.04.28
申请人
NATIONAL INSTITUTE OF HEALTH;DENKA SEIKEN CO., LTD.;CHIBA-KEN;JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE